<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0064">
 <label>64.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>O’Donnell</surname>
   <given-names>MR</given-names>
  </string-name>, 
  <string-name>
   <surname>Padayatchi</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Daftary</surname>
   <given-names>A</given-names>
  </string-name>, et al. 
  <article-title>Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection</article-title>. 
  <source>
   <italic toggle="yes">Lancet HIV</italic>
  </source>. 
  <year>2019</year>;
  <volume>6</volume>(
  <issue>3</issue>):
  <fpage>e201</fpage>–
  <lpage>e204</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/S2352-3018(19)30035-9</pub-id>
  <pub-id pub-id-type="pmid">30846058</pub-id>
 </mixed-citation>
</ref>
